In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use

The endothelial cells lining the brain capillaries separate the blood from the brain parenchyma. The endothelial monolayer of the brain capillaries serves both as a crucial interface for exchange of nutrients, gases, and metabolites between blood and brain, and as a barrier for neurotoxic components of plasma and xenobiotics. This “blood-brain barrier” function is a major hindrance for drug uptake into the brain parenchyma. Cell culture models, based on either primary cells or immortalized brain endothelial cell lines, have been developed, in order to facilitate in vitro studies of drug transport to the brain and studies of endothelial cell biology and pathophysiology. In this review, we aim to give an overview of established in vitro blood–brain barrier models with a focus on their validation regarding a set of well-established blood–brain barrier characteristics. As an ideal cell culture model of the blood–brain barrier is yet to be developed, we also aim to give an overview of the advantages and drawbacks of the different models described.

[1]  K. Hayashi,et al.  Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells , 2007, Cellular and molecular neurobiology.

[2]  中川 慎介 A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes , 2009 .

[3]  P. Couraud,et al.  The hCMEC/D3 cell line as a model of the human blood brain barrier , 2013, Fluids and Barriers of the CNS.

[4]  M. Dehouck,et al.  Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier , 1995 .

[5]  G. Superti-Furga,et al.  A Call for Systematic Research on Solute Carriers , 2015, Cell.

[6]  Birger Brodin,et al.  Paracellular Tightness and Claudin-5 Expression is Increased in the BCEC/Astrocyte Blood–Brain Barrier Model by Increasing Media Buffer Capacity During Growth , 2010, The AAPS Journal.

[7]  Bo Li,et al.  Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis. , 2015, The international journal of biochemistry & cell biology.

[8]  L. Fenart,et al.  Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. , 2010, Journal of Alzheimer's disease : JAD.

[9]  Ignacio A. Romero,et al.  Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models , 2011, Journal of Neuroscience Methods.

[10]  M. Furuse Molecular basis of the core structure of tight junctions. , 2010, Cold Spring Harbor perspectives in biology.

[11]  N J Abbott,et al.  Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.

[12]  J. Leers,et al.  Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element , 2008, Molecular and Cellular Endocrinology.

[13]  L. Fenart,et al.  Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.

[14]  R. Gold,et al.  Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis , 2010, Multiple sclerosis.

[15]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[16]  H. G. van Eijk,et al.  Quantification of Different Transferrin Receptor Pools in Primary Cultures of Porcine Blood‐Brain Barrier Endothelial Cells , 1995, Journal of neurochemistry.

[17]  H. Galla,et al.  Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A , 2014, The Journal of Neuroscience.

[18]  Z. Nagy,et al.  Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  Kathrin Benson,et al.  Impedance-based cell monitoring: barrier properties and beyond , 2013, Fluids and Barriers of the CNS.

[20]  A. Nimmerjahn,et al.  Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke , 2014, Neuron.

[21]  H. Galla,et al.  Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood–brain barrier after CITCO activation , 2013, Brain Research.

[22]  D. Greenblatt,et al.  Induction of P‐glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells , 2007, The Journal of pharmacy and pharmacology.

[23]  P. Couraud,et al.  Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes , 2014, PloS one.

[24]  H. Galla,et al.  Control of the Blood–Brain Barrier by Glucocorticoids and the Cells of the Neurovascular Unit , 2009, Annals of the New York Academy of Sciences.

[25]  H. Okada,et al.  Insulin Fragments as a Carrier for Peptide Delivery Across the Blood–Brain Barrier , 1994, Pharmaceutical Research.

[26]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[27]  B. Barres,et al.  The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells , 2010, PloS one.

[28]  J. Penney,et al.  Primary culture of capillary endothelium from rat brain , 1981, In Vitro.

[29]  Michel Demeule,et al.  Identification and Design of Peptides as a New Drug Delivery System for the Brain , 2008, Journal of Pharmacology and Experimental Therapeutics.

[30]  L. Campbell,et al.  Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood–brain barrier model for drug uptake and transport studies , 2003, Brain Research.

[31]  J. Lachowicz,et al.  ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice , 2014, Molecular Cancer Therapeutics.

[32]  H. Galla,et al.  Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties , 2014, Cell and Tissue Research.

[33]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  L. Fenart,et al.  Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model , 2009, Brain Research.

[35]  M. Dehouck,et al.  Radiation-induced blood–brain barrier damages: An in vitro study , 2012, Brain Research.

[36]  Andrew P. McMahon,et al.  Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature , 2008, Science.

[37]  M. Karnovsky,et al.  Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures , 1987, Brain Research.

[38]  E. Wagner,et al.  Oncogenes in the study of endothelial cell growth and differentiation. , 1994, Seminars in cancer biology.

[39]  W H Oldendorf,et al.  Amino acid assignment to one of three blood-brain barrier amino acid carriers. , 1976, The American journal of physiology.

[40]  H. Galla,et al.  Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone , 2005, Brain Research.

[41]  R. Béliveau,et al.  Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2 , 2008, Journal of neurochemistry.

[42]  L. Fenart,et al.  Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier , 2004, Brain Research.

[43]  T. Terasaki,et al.  Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. , 2013, Molecular pharmaceutics.

[44]  E. Chevet,et al.  Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization , 2014, Nature Medicine.

[45]  H. Galla,et al.  Impedance analysis of epithelial and endothelial cell monolayers cultured on gold surfaces. , 1996, Journal of biochemical and biophysical methods.

[46]  C. Förster,et al.  Cloning and characterization of the murine claudin-5 promoter , 2009, Molecular and Cellular Endocrinology.

[47]  M. Dehouck,et al.  Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. , 2012, Drug discovery today.

[48]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[49]  L. Rubin,et al.  A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.

[50]  P. Cancilla,et al.  gamma-Glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. , 1980, Science.

[51]  Hans-Joachim Galla,et al.  An improved low-permeability in vitro-model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol , 1999, Brain Research.

[52]  Tanja Eisenblätter,et al.  A new multidrug resistance protein at the blood-brain barrier. , 2002, Biochemical and biophysical research communications.

[53]  B. Orsolits,et al.  Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit. , 2013, Journal of Alzheimer's disease : JAD.

[54]  N. Joan Abbott,et al.  Establishment of a simplified in vitro porcine blood–brain barrier model with high transendothelial electrical resistance , 2013, Brain Research.

[55]  H. Galla,et al.  Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. , 1998, Biochemical and biophysical research communications.

[56]  I. Zuhorn,et al.  Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier , 2014, Pharmaceutics.

[57]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[58]  C. Förster,et al.  Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murine in vitro system , 2005, The Journal of physiology.

[59]  Szilvia Veszelka,et al.  Tesmilifene modifies brain endothelial functions and opens the blood–brain/blood–glioma barrier , 2015, Journal of neurochemistry.

[60]  P. Steeg,et al.  Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer , 2009, Pharmaceutical Research.

[61]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[62]  G. Fricker,et al.  A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[63]  T. Hartung,et al.  Induction of blood‐brain barrier properties in cultured brain capillary endothelial cells: Comparison between primary glial cells and C6 cell line , 2005, Glia.

[64]  A. Nishi,et al.  The Blood–Brain Barrier Permeability of Geissoschizine Methyl Ether in Uncaria Hook, a Galenical Constituent of the Traditional Japanese Medicine Yokukansan , 2011, Cellular and Molecular Neurobiology.

[65]  H. Fujita,et al.  Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers. , 1997, Neurological research.

[66]  J. Drewe,et al.  Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium , 1996, British journal of pharmacology.

[67]  R. Bordet,et al.  Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. , 2009, Current neurovascular research.

[68]  K. Abe,et al.  Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. , 2010, Current neurovascular research.

[69]  Sean P. Palecek,et al.  A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources , 2014, Scientific Reports.

[70]  U. Massing,et al.  Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries , 2009, Journal of drug targeting.

[71]  L. Fenart,et al.  In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes , 2015, Brain Research.

[72]  S. Rapoport,et al.  Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride , 1986, Journal of neurochemistry.

[73]  Xiaoyu Xu,et al.  A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat , 2013, International journal of biological sciences.

[74]  L. Fenart,et al.  Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier , 1998, Pharmaceutical Research.

[75]  I. Romero,et al.  Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation , 2009, Journal of cellular and molecular medicine.

[76]  P. Lantos,et al.  Uptake of leucine and alanine by cultured cerebral capillary endothelial cells , 1989, Brain Research.

[77]  Edward J. Rapp,et al.  Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  Uwe Karst,et al.  Impact of Manganese on and Transfer across Blood-Brain and Blood-Cerebrospinal Fluid Barrier in Vitro* , 2012, The Journal of Biological Chemistry.

[79]  K. Hayashi,et al.  Effects of hypoxia on endothelial/pericytic co-culture model of the blood–brain barrier , 2004, Regulatory Peptides.

[80]  Calvin J Kuo,et al.  Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis , 2009, Proceedings of the National Academy of Sciences.

[81]  D. Breimer,et al.  Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood–brain barrier , 2001, AIDS.

[82]  H. Humpf,et al.  Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity , 2011, Molecular nutrition & food research.

[83]  Maxime Culot,et al.  A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells , 2014, PloS one.

[84]  H. Davies,et al.  Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro , 2013, PLoS ONE.

[85]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[86]  K. Scearce-Levie,et al.  Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates , 2014, Science Translational Medicine.

[87]  Helga E de Vries,et al.  Puromycin‐purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction , 2006, Journal of neurochemistry.

[88]  P. Cancilla,et al.  Cerebral microvessels and derived cells in tissue culture: Isolation and preliminary characterization , 1979, In Vitro.

[89]  M. Dehouck,et al.  Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood–brain barrier disruption through glia activation: Role of pro-inflammatory cytokines and nitric oxide , 2006, Neuroscience.

[90]  Anthony R. Calabria,et al.  A Genomic Comparison of in vivo and in vitro Brain Microvascular Endothelial Cells , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[91]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[92]  Hiroshi Yamamoto,et al.  Induction of various blood‐brain barrier properties in non‐neural endothelial cells by close apposition to co‐cultured astrocytes , 1997, Glia.

[93]  T. Reese,et al.  JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN , 1969, The Journal of cell biology.

[94]  R. Bendayan,et al.  1α,25‐Dihydroxyvitamin D3‐liganded vitamin D receptor increases expression and transport activity of P‐glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells , 2012, Journal of neurochemistry.

[95]  M. Stins,et al.  Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. , 2001, Microbial pathogenesis.

[96]  Stanley E. Lazic,et al.  Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models , 2012, PloS one.

[97]  T. Abbruscato,et al.  Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. , 1999, The Journal of pharmacology and experimental therapeutics.

[98]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[99]  C. Ringbom,et al.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[100]  S. Meuth,et al.  Glucocorticoid Insensitivity at the Hypoxic Blood–Brain Barrier Can Be Reversed by Inhibition of the Proteasome , 2011, Stroke.

[101]  L. Fenart,et al.  Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium , 2005, Laboratory Investigation.

[102]  D. Miller,et al.  Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. , 1998, Biochemical and biophysical research communications.

[103]  M. Deli,et al.  N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers , 2003, Inflammation Research.

[104]  H. Galla,et al.  Pericyte–endothelial cell interaction increases MMP-9 secretion at the blood–brain barrier in vitro , 2008, Brain Research.

[105]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[106]  S. Koizumi,et al.  In Vitro Blood-Brain Barrier Models Using Brain Capillary Endothelial Cells Isolated from Neonatal and Adult Rats Retain Age-Related Barrier Properties , 2013, PloS one.

[107]  C. Remacle,et al.  Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood–brain barrier , 2002, Journal of Neuroscience Methods.

[108]  T. Tsuruo,et al.  P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. , 1992, Life sciences.

[109]  P. Wielinga,et al.  Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy , 2004, Molecular and Cellular Biology.

[110]  W. Pardridge,et al.  Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate , 1995, Pharmaceutical Research.

[111]  R. Keep,et al.  Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase , 2003, Journal of Cell Science.

[112]  M. Danhof,et al.  Characterization and Modulation of the Transferrin Receptor on Brain Capillary Endothelial Cells , 2004, Pharmaceutical Research.

[113]  B. Sperlágh,et al.  Oxygen–glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood–brain barrier , 2011, Neurochemistry International.

[114]  A. Godoy,et al.  Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain , 1999, Brain Research.

[115]  H. Galla,et al.  The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. , 2011, The international journal of biochemistry & cell biology.

[116]  M. Lakomek,et al.  Alkylglycerol opening of the blood–brain barrier to small and large fluorescence markers in normal and C6 glioma‐bearing rats and isolated rat brain capillaries , 2003, British journal of pharmacology.

[117]  J. Piontek,et al.  Structure and function of claudins. , 2008, Biochimica et biophysica acta.

[118]  R. Cecchelli,et al.  A polarized localization of amino acid/carnitine transporter B(0,+) (ATB(0,+)) in the blood-brain barrier. , 2008, Biochemical and biophysical research communications.

[119]  C. Förster,et al.  The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier , 2014, Front. Cell. Neurosci..

[120]  H. Galla,et al.  Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system. , 1998, Biochemical and biophysical research communications.

[121]  W H Oldendorf,et al.  Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. , 1973, The American journal of physiology.

[122]  H. Galla,et al.  Transport of Arylsulfatase A across the Blood-Brain Barrier in Vitro* , 2011, The Journal of Biological Chemistry.

[123]  K. Audus,et al.  Evaluation of the Role of P-Glycoprotein in Ivermectin Uptake by Primary Cultures of Bovine Brain Microvessel Endothelial Cells , 1998, Neurochemical Research.

[124]  H. Galla,et al.  A microscopic in vitro study of neutrophil diapedesis across the blood-brain barrier , 2011 .

[125]  M. Weinand,et al.  Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier , 2010, Nature Protocols.

[126]  N. Abbott,et al.  An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. , 2012, Methods in molecular biology.

[127]  T. Terasaki,et al.  A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters , 2007, Brain Research.

[128]  S. Liebner,et al.  The Wnt/Planar Cell Polarity Signaling Pathway Contributes to the Integrity of Tight Junctions in Brain Endothelial Cells , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[129]  Kjell Johnson,et al.  Porcine Brain Microvessel Endothelial Cells as an in Vitro Model to Predict in Vivo Blood-Brain Barrier Permeability , 2006, Drug Metabolism and Disposition.

[130]  C. Lohmann,et al.  Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays , 2002, Journal of drug targeting.

[131]  Angelique van den Heuvel,et al.  Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats , 2014, Journal of drug targeting.

[132]  L. Fenart,et al.  Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.

[133]  Thomas J. Raub,et al.  Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. , 1992, Experimental cell research.

[134]  C. Förster,et al.  Glucocorticoids Increase VE-Cadherin Expression and Cause Cytoskeletal Rearrangements in Murine Brain Endothelial cEND Cells , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[135]  R. Skinner,et al.  A detailed method for preparation of a functional and flexible blood–brain barrier model using porcine brain endothelial cells☆ , 2013, Brain Research.

[136]  M. Khrestchatisky,et al.  Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport , 2014, Journal of visualized experiments : JoVE.

[137]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[138]  R. Gold,et al.  Differential Cytokine Release from Brain Microvascular Endothelial Cells Treated with Dexamethasone and Multiple Sclerosis Patient Sera , 2013 .

[139]  K. P. Lehre,et al.  The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction , 2010, Glia.

[140]  Á. Kittel,et al.  Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[141]  L. B. Thomsen,et al.  A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes , 2015, PloS one.

[142]  B. Sharrack,et al.  Cytokine-induced changes in the gene expression profile of a human cerebral microvascular endothelial cell-line, hCMEC/D3 , 2013, Fluids and Barriers of the CNS.

[143]  F. Charron,et al.  The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.

[144]  P. Couraud,et al.  Meningococcal Type IV Pili Recruit the Polarity Complex to Cross the Brain Endothelium , 2009, Science.

[145]  M. Danhof,et al.  Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[146]  M. Yliperttula,et al.  Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[147]  Thomas J. Raub,et al.  Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells , 1991, Journal of cellular physiology.

[148]  V. Teichberg,et al.  Mechanisms of Glutamate Efflux at the Blood—Brain Barrier: Involvement of Glial Cells , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[149]  C. Daumas-Duport,et al.  ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier , 2008, Journal of neurochemistry.

[150]  R. Bordet,et al.  Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier , 2009 .

[151]  P. Couraud,et al.  Cilostazol Strengthens Barrier Integrity in Brain Endothelial Cells , 2013, Cellular and Molecular Neurobiology.

[152]  M. Ott,et al.  Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR , 2009, Journal of Pharmacology and Experimental Therapeutics.

[153]  L. Fenart,et al.  Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells , 2013, Brain Research.

[154]  P. L. Rodriguez,et al.  The proinflammatory peptide substance P promotes blood–brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions , 2014, International journal of cancer.

[155]  B. Brodin,et al.  Generation of primary cultures of bovine brain endothelial cells and setup of cocultures with rat astrocytes. , 2014, Methods in molecular biology.

[156]  I. Klatzo,et al.  Isolation of brain capillaries: a simplified technique , 1976, Brain Research.

[157]  L. Ferrarini,et al.  Wnt Activation of Immortalized Brain Endothelial Cells as a Tool for Generating a Standardized Model of the Blood Brain Barrier In Vitro , 2013, PloS one.

[158]  R. Weaver,et al.  Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. , 2009, Biochemical pharmacology.

[159]  R. Béliveau,et al.  Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2 , 2008, British journal of pharmacology.

[160]  K. Arita,et al.  C-Type Natriuretic Peptide Modulates Permeability of the Blood–Brain Barrier , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[161]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[162]  G. Lupo,et al.  Endothelial PKCα-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes? , 2014, Biochimie.

[163]  K. Audus,et al.  Characterization of an In Vitro Blood–Brain Barrier Model System for Studying Drug Transport and Metabolism , 1986, Pharmaceutical Research.

[164]  C. Beglinger,et al.  Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[165]  T. Terasaki,et al.  Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics. , 2015, Journal of pharmaceutical sciences.

[166]  K. Giacomini,et al.  Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier , 2013, Clinical pharmacology and therapeutics.

[167]  H. Galla,et al.  Regulation of major efflux transporters under inflammatory conditions at the blood‐brain barrier in vitro , 2009, Journal of neurochemistry.

[168]  P. Couraud,et al.  Immortalized Human Brain Endothelial Cell Line HCMEC/D3 as a Model of the Blood-Brain Barrier Facilitates In Vitro Studies of Central Nervous System Infection by Cryptococcus neoformans , 2009, Eukaryotic Cell.

[169]  K. Zuideveld,et al.  Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[170]  I. Tamai,et al.  Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies , 2004, Pharmaceutical Research.

[171]  L. Fenart,et al.  In vitro model for evaluating drug transport across the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[172]  H. Davies,et al.  Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[173]  C. Förster,et al.  Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model , 2012, Journal of visualized experiments : JoVE.

[174]  J. Piontek,et al.  Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[175]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[176]  A. Moses,et al.  Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies , 2013, Fluids and Barriers of the CNS.

[177]  E. Aronica,et al.  Retinoic Acid Induces Blood–Brain Barrier Development , 2013, The Journal of Neuroscience.

[178]  M. Gumbleton,et al.  Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting , 2007, Journal of drug targeting.

[179]  T. Terasaki,et al.  Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. , 1991, The Journal of pharmacology and experimental therapeutics.

[180]  C. Förster,et al.  Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.

[181]  K. Müller,et al.  Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. , 2002, Experimental and molecular pathology.

[182]  P. Turner The Blood-Brain Barrier in Health and Disease , 1987 .

[183]  A. Boer,et al.  Diphtheria toxin receptor-targeted brain drug delivery , 2005 .

[184]  B. Thiers Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[185]  F. Joó,et al.  A procedure for the isolation of capillaries from rat brain. , 1973, Cytobios.

[186]  N. Rothwell,et al.  An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood–brain barrier model , 2012, Brain Research.

[187]  P. Couraud,et al.  Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.

[188]  P. Couraud,et al.  ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected]. , 2010, Molecular pharmaceutics.

[189]  A. D'emanuele,et al.  Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.

[190]  H. Davies,et al.  Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123 , 2009, Brain Research.

[191]  Y. Kase,et al.  The Blood–Brain Barrier Permeability of 18β-Glycyrrhetinic Acid, a Major Metabolite of Glycyrrhizin in Glycyrrhiza Root, a Constituent of the Traditional Japanese Medicine Yokukansan , 2012, Cellular and Molecular Neurobiology.

[192]  Takashi Suzuki,et al.  Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors , 2011, Journal of neurochemistry.

[193]  Anirvan Ghosh,et al.  Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle , 2014, Neuron.

[194]  F. Pifferi,et al.  n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells , 2010, Neurochemistry International.

[195]  P. Gaillard,et al.  Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[196]  Hong Zhang,et al.  The FASEB Journal express article 10.1096/fj.02-1131fje. Published online September 4, 2003. Expression and functional characterization of ABCG2 in brain endothelial cells and vessels , 2022 .

[197]  Thomas P Davis,et al.  Oxidative Stress Increases Blood–Brain Barrier Permeability and Induces Alterations in Occludin during Hypoxia–Reoxygenation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[198]  Yunhui Liu,et al.  Bradykinin increases blood–tumor barrier permeability by down‐regulating the expression levels of ZO‐1, occludin, and claudin‐5 and rearranging actin cytoskeleton , 2008, Journal of neuroscience research.

[199]  Bradley E. Enerson,et al.  Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. , 1997, The American journal of physiology.

[200]  I. Blasig,et al.  Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation , 2006, Proteomics.

[201]  H. Kobayashi,et al.  Adrenomedullin regulates blood–brain barrier functions in vitro , 2001, Neuroreport.

[202]  I. Wilhelm,et al.  In vitro models of the blood-brain barrier. , 2011, Acta neurobiologiae experimentalis.

[203]  K. Audus,et al.  Angiotensin Peptide Regulation of Bovine Brain Microvessel Endothelial Cell Monolayer Permeability , 1991, Journal of cardiovascular pharmacology.

[204]  M. Dehouck,et al.  Drug transfer across the blood-brain barrier: Correlation between “in vitro” and “in vivo” models , 1992, Neurochemistry International.

[205]  S. Cole,et al.  Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .

[206]  T. Abbruscato,et al.  An in vitro model of ischemic stroke. , 2012, Methods in molecular biology.

[207]  M. Dehouck,et al.  Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. , 1996, The American journal of physiology.

[208]  K D Pettigrew,et al.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. , 1978, The American journal of physiology.

[209]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[210]  R. Borchardt,et al.  VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. , 2001, American journal of physiology. Heart and circulatory physiology.

[211]  W. Pardridge,et al.  Selective expression of the large neutral amino acid transporter at the blood-brain barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[212]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[213]  P Couvreur,et al.  Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties , 2005, Journal of neurochemistry.

[214]  R. Uzbekov,et al.  Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. , 2011, Current neurovascular research.

[215]  Mingyuan Gao,et al.  Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. , 2012, ACS nano.

[216]  J. Hakkarainen,et al.  Re-evaluation of the role of P-glycoprotein in in vitro drug permeability studies with the bovine brain microvessel endothelial cells , 2014, Xenobiotica; the fate of foreign compounds in biological systems.

[217]  M. Dehouck,et al.  Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture , 1989, Journal of neurochemistry.

[218]  J. Drewe,et al.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. , 2000, Molecular pharmacology.

[219]  C Crone,et al.  Facilitated transfer of glucose from blood into brain tissue. , 1965, The Journal of physiology.

[220]  L. Fenart,et al.  Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier. , 2013, Current Alzheimer research.

[221]  A. Vezzani,et al.  Significance of MDR1 and multiple drug resistance in refractory human epileptic brain , 2004 .

[222]  D. Breimer,et al.  Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier , 2000, Pharmaceutical Research.

[223]  F. Joó,et al.  Production of pure primary rat cerebral endothelial cell culture: a comparison of different methods. , 1997, Neurobiology.

[224]  B. Brodin,et al.  An Electrically Tight In Vitro Blood–Brain Barrier Model Displays Net Brain-to-Blood Efflux of Substrates for the ABC Transporters, P-gp, Bcrp and Mrp-1 , 2014, The AAPS Journal.

[225]  G. Thom,et al.  Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitromodels of the rat blood-brain barrier and blood-spinal cord barrier , 2013, BMC Neuroscience.

[226]  H. Galla,et al.  Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier , 2013, Brain Research.

[227]  M. Kamiński,et al.  Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus. , 2010, Biochimica et biophysica acta.

[228]  S. Olesen,et al.  Electrical resistance of brain microvascular endothelium , 1982, Brain Research.

[229]  T. Tsuruo,et al.  Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-β production , 2005, Brain Research.

[230]  M. Pirmohamed,et al.  Transport of gabapentin by LAT1 (SLC7A5). , 2013, Biochemical pharmacology.

[231]  J. Antel,et al.  Kinin B1 Receptor Expression and Function on Human Brain Endothelial Cells , 2000, Journal of neuropathology and experimental neurology.

[232]  N. Cho,et al.  Cancer‐associated fibroblast promote transmigration through endothelial brain cells in three‐dimensional in vitro models , 2014, International journal of cancer.

[233]  I. Wilhelm,et al.  Transmigration of Melanoma Cells through the Blood-Brain Barrier: Role of Endothelial Tight Junctions and Melanoma-Released Serine Proteases , 2011, PloS one.

[234]  L. Rubin,et al.  Lysophosphatidic Acid Increases Tight Junction Permeability in Cultured Brain Endothelial Cells , 1997, Journal of neurochemistry.

[235]  P. Couraud,et al.  Expression and localization of claudins-3 and -12 in transformed human brain endothelium , 2012, Fluids and Barriers of the CNS.

[236]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[237]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[238]  S. Krähenbühl,et al.  The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies , 2008, Journal of neurochemistry.

[239]  S. D. de Morais,et al.  Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. , 2009, Pharmacological research.

[240]  H. Galla,et al.  Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. , 2000, Brain research. Brain research protocols.

[241]  David S. Miller,et al.  Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease , 2010, Molecular Pharmacology.

[242]  T. Yoshimoto,et al.  Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation , 1996, Neuroscience Letters.

[243]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[244]  Mandy B. Esch,et al.  TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.

[245]  E. Jaffe,et al.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells. , 1973, The Journal of clinical investigation.

[246]  J. Greenwood,et al.  Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. , 1992, Journal of cell science.

[247]  F. Pifferi,et al.  n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[248]  Donald W. Miller,et al.  Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. , 1999, Life sciences.

[249]  L. Fenart,et al.  A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.

[250]  J. Sahi,et al.  Temporal expression of transporters and receptors in a rat primary co-culture blood–brain barrier model , 2014, Xenobiotica; the fate of foreign compounds in biological systems.

[251]  C. Förster,et al.  Dexamethasone induces the expression of metalloproteinase inhibitor TIMP‐1 in the murine cerebral vascular endothelial cell line cEND , 2007, The Journal of physiology.

[252]  J. Leers,et al.  Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific , 2006, The Journal of physiology.

[253]  M. Barrand,et al.  Localisation of breast cancer resistance protein in microvessel endothelium of human brain , 2002, Neuroreport.

[254]  R. Gibson,et al.  Transport of interleukin‐1 across cerebromicrovascular endothelial cells , 2009, British journal of pharmacology.

[255]  G. Fricker,et al.  Permeability of porcine blood brain barrier to somatostatin analogues , 2002, British journal of pharmacology.

[256]  J. C. Belmonte,et al.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells , 2011, Nature Medicine.

[257]  E. Ezan,et al.  A co-culture-based model of human blood–brain barrier: application to active transport of indinavir and in vivo–in vitro correlation , 2002, Brain Research.

[258]  H. Koepsell,et al.  Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells , 2012, Neuroscience Letters.

[259]  B. Engelhardt,et al.  Comparison of Immortalized bEnd5 and Primary Mouse Brain Microvascular Endothelial Cells as in vitro Blood–Brain Barrier Models for the Study of T Cell Extravasation , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[260]  J. Schneider,et al.  Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance , 2015, Nature Neuroscience.

[261]  Á. Kittel,et al.  Exposure to Lipopolysaccharide and/or Unconjugated Bilirubin Impair the Integrity and Function of Brain Microvascular Endothelial Cells , 2012, PloS one.

[262]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[263]  Jörg Meyer,et al.  Characterization of γ-glutamyl transpeptidase activity of cultured endothelial cells from porcine brain capillaries , 1989, Cell and Tissue Research.

[264]  K. Dorovini-Zis,et al.  Ultrastructural localization of factor VIII-related antigen in cultured human brain microvessel endothelial cells. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[265]  F. Joó,et al.  Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3',5'‐monophosphate , 1995, Experimental physiology.

[266]  N. Abbott Anatomy and Physiology of the Blood–Brain Barriers , 2014 .

[267]  W. Löscher,et al.  The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses , 2007, Clinical Cancer Research.

[268]  Wei Feng,et al.  Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. , 2009, International journal of pharmaceutics.

[269]  V. Teichberg,et al.  Closing the gap between the in-vivo and in-vitro blood–brain barrier tightness , 2009, Brain Research.

[270]  N. Ichikawa,et al.  Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro. , 1996, Journal of pharmacological and toxicological methods.

[271]  M. Pirmohamed,et al.  A Multi-System Approach Assessing the Interaction of Anticonvulsants with P-gp , 2013, PloS one.

[272]  B. Brodin,et al.  In vitro evidence for the brain glutamate efflux hypothesis: Brain endothelial cells cocultured with astrocytes display a polarized brain‐to‐blood transport of glutamate , 2012, Glia.

[273]  Maxime Culot,et al.  An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[274]  F. Joó,et al.  Histamine induces a selective albumin permeation through the blood-brain barrierin vitro , 1995, Inflammation Research.

[275]  Christopher M Waters,et al.  Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. , 2008, American journal of physiology. Cell physiology.

[276]  R. Béliveau,et al.  New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration. , 2010, Journal of medicinal chemistry.

[277]  Y. Ueta,et al.  Chronic adrenomedullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. , 2003, Acta neurochirurgica. Supplement.

[278]  E. Lo,et al.  The Vasculome of the Mouse Brain , 2012, PloS one.

[279]  Donald W. Miller,et al.  Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[280]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[281]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[282]  G. Goldstein,et al.  Brain microvessel endothelial cells in tissue culture: A model for study of blood‐brain barrier permeability , 1983, Annals of neurology.

[283]  C. Daumas-Duport,et al.  Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. , 2011, Molecular pharmaceutics.

[284]  C. Morris,et al.  Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain , 1992, Journal of neurochemistry.

[285]  T. Schwerdtle,et al.  The Influence of Silver Nanoparticles on the Blood-Brain and the Blood-Cerebrospinal Fluid Barrier in vitro , 2014 .

[286]  P Delorme,et al.  An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.

[287]  J. Pachter,et al.  Where is the blood–brain barrier … really? , 2005, Journal of neuroscience research.

[288]  G. Fricker,et al.  Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and Lipopolysaccharide , 2006, Molecular Pharmacology.

[289]  H. Galla,et al.  Methods to assess pericyte-endothelial cell interactions in a coculture model. , 2011, Methods in molecular biology.

[290]  B. Hof,et al.  Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function in multiple sclerosis , 2014, Acta Neuropathologica.

[291]  T. Fujiwara,et al.  Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. , 2010, Biochemical and biophysical research communications.

[292]  Hyun Seok Song,et al.  SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.

[293]  J. Provias,et al.  The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease , 2011, Journal of neuroscience research.

[294]  J. Kros,et al.  Glut1/SLC2A1 is crucial for the development of the blood‐brain barrier in vivo , 2010, Annals of neurology.

[295]  Bradley E. Enerson,et al.  The Rat Blood—Brain Barrier Transcriptome , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[296]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[297]  S. Krähenbühl,et al.  Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier , 2009, Cellular and Molecular Neurobiology.

[298]  J. Park,et al.  Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier. , 2011, Anticancer research.

[299]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.